Xtant Medical Holdings, Inc. XTNT

Full chart Compare
Set alert

Price alert · XTNT

All alert types
0.30 USD +0.02 (+6.47%)

At closeNov 4, 2026, 4:00 PM EST

0.30 0.00 0.00%

After hours · Nov 4, 4:00 PM ET

0.28 Day range 0.32
0.27 52-week range 0.84
YTD
-62.05%
1 year
-60.00%

Revenue & Expenses

Revenue by
Orthobiologics → Revenue: $72.89MRevenue → Gross Profit: $84.27MGross Profit → Net Income: $4.97MGross Profit → Selling, General & Admin: $74.89MRevenue → Cost of Revenue: $49.65MGross Profit → Research & Development: $2.10MGross Profit → Other Expenses: $283.00KGross Profit → Income Tax: $2.03MSpinal Implant → Revenue: $42.31MLicense Revenue → Revenue: $18.72MGross Profit$84.27MCost of Revenue$49.65MNet Income$4.97MSelling, General & Admin$74.89MResearch & Development$2.10MOther Expenses$283.00KIncome Tax$2.03MRevenue$133.93MOrthobiologics$72.89MSpinal Implant$42.31MLicense Revenue$18.72M

Latest period ending Dec 31, 2025 · select a line to chart its full history

XTNT annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
133.93M117.27M91.30M57.97M55.26M
84.27M68.22M55.47M32.14M32.49M
7.28M-12.07M-10.16M-6.75M-3.85M
4.97M-16.45M660.00K-8.48M-4.85M
0.04-0.120.01-0.09-0.06
XTNT annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
17.33M6.22M5.92M20.51M18.39M
94.14M93.84M92.61M60.23M54.69M
43.19M50.87M41.26M26.06M23.81M
28.72M35.14M23.56M17.07M16.84M
50.95M42.96M51.35M34.17M30.88M
XTNT annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
12.55M-11.90M-9.52M-5.34M439.00K
7.90M-3.73M-24.78M-1.56M-1.89M
-9.57M16.07M19.69M9.02M17.50M
-2.15M-3.73M-1.28M-1.56M-1.89M
11.11M298.00K-14.58M2.12M16.05M